NCT05901389

Brief Summary

The goal of this clinical trial is to learn about the effects on postoperative analgesia of continuous lidocaine infusion via closed chest drainage tube for patients undergoing thoracoscopic partial lung resection. The main questions it aims to answer are:

  • To explore whether continuous lidocaine pumping via closed chest drainage tube has good analgesic and anti-inflammatory effects for patients undergoing partial thoracoscopic pneumonectomy.
  • Whether the multimodal analgesia combined with continuous lidocaine pump can reduce the postoperative application of opioids, reduce the occurrence of postoperative complications, and promote the recovery of postoperative lung function and accelerate recovery. For participants who undergoing the thoracoscopic partial lung resection with postoperative indwelling drainage tube, the epidural tube fixed in the drainage tube is connected to the completed infusion pump (marking the chest drain for analgesia). The comparison group only accept the intravenous analgesia after surgery.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
451

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jun 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 3, 2023

Completed
1 month until next milestone

Study Start

First participant enrolled

June 7, 2023

Completed
6 days until next milestone

First Posted

Study publicly available on registry

June 13, 2023

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 22, 2023

Completed
8 days until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2023

Completed
Last Updated

September 24, 2026

Status Verified

July 1, 2023

Enrollment Period

7 months

First QC Date

May 3, 2023

Last Update Submit

September 20, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • postoperative pain scoreNRS

    The primary outcome is the incidence of a numeric rating scale (NRS) pain score \> 3 on coughing/movement at 24 hours postoperatively (movement-evoked pain only).

    Day 1

Secondary Outcomes (15)

  • Changes in postoperative pain

    Day 2

  • the use of flurbiprofen axetil

    Day 3

  • the use of dolantin

    Day 3

  • the use of opioids

    Day 2

  • postoperative adverse events

    Day 3

  • +10 more secondary outcomes

Study Arms (2)

Lidocaine (intrapleural continuous infusion) + reduced-dose sufentanil PCIA

EXPERIMENTAL

Patients receive continuous intrapleural lidocaine infusion via the closed chest drainage tube (pulse 1 mL/30 min + continuous 2 mL/h) combined with reduced-dose sufentanil patient-controlled intravenous analgesia (PCIA, 1.0-1.5 ”g/kg for 48 h).

Drug: LidocaineDrug: Sufentanil

Standard-dose sufentanil PCIA

ACTIVE COMPARATOR

Patients receive standard-dose sufentanil PCIA (2.0-2.5 ”g/kg for 48 h) alone.

Drug: Sufentanil

Interventions

Continuous intrapleural infusion via epidural tube fixed in the closed chest drainage tube, connected to an electronic analgesic pump (pulse 1 mL/30 min + continuous 2 mL/h).

Lidocaine (intrapleural continuous infusion) + reduced-dose sufentanil PCIA

Patient-controlled intravenous analgesia (PCIA): reduced dose 1.0-1.5 ”g/kg in the lidocaine arm, standard dose 2.0-2.5 ”g/kg in the control arm, both for 48 h.

Lidocaine (intrapleural continuous infusion) + reduced-dose sufentanil PCIAStandard-dose sufentanil PCIA

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • participants ages 18-70 years.
  • participants undergoing thoracoscopic partial lung resection with an indwelling drainage tube after surgery.
  • American Society of Anesthesiologists classification (ASA)I-III.

You may not qualify if:

  • severe heart failure, cardiac arrhythmias,the New York Heart Association(NYHA) classification≄III.
  • hypersensitivity to lidocaine,History of local anesthetic poisoning.
  • severe renal or hepatic dysfunction.
  • body mass index (BMI)\>35 kg m-2.
  • severe pleural adhesions.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Qilu Hospital

Jinan, Shandong, China

Location

Related Publications (26)

  • Abdallah FW, Brull R. Is sciatic nerve block advantageous when combined with femoral nerve block for postoperative analgesia following total knee arthroplasty? A systematic review. Reg Anesth Pain Med. 2011 Sep-Oct;36(5):493-8. doi: 10.1097/AAP.0b013e318228d5d4.

    PMID: 21857266BACKGROUND
  • Barletta M, Reed R. Local Anesthetics: Pharmacology and Special Preparations. Vet Clin North Am Small Anim Pract. 2019 Nov;49(6):1109-1125. doi: 10.1016/j.cvsm.2019.07.004. Epub 2019 Aug 30.

    PMID: 31474415BACKGROUND
  • Becker DE, Reed KL. Local anesthetics: review of pharmacological considerations. Anesth Prog. 2012 Summer;59(2):90-101; quiz 102-3. doi: 10.2344/0003-3006-59.2.90.

    PMID: 22822998BACKGROUND
  • Camorcia M, Capogna G, Columb MO. Effect of sex and pregnancy on the potency of intrathecal bupivacaine: determination of ED(5)(0) for motor block with the up-down sequential allocation method. Eur J Anaesthesiol. 2011 Apr;28(4):240-4.

    PMID: 21513074BACKGROUND
  • Capdevila X, Pirat P, Bringuier S, Gaertner E, Singelyn F, Bernard N, Choquet O, Bouaziz H, Bonnet F; French Study Group on Continuous Peripheral Nerve Blocks. Continuous peripheral nerve blocks in hospital wards after orthopedic surgery: a multicenter prospective analysis of the quality of postoperative analgesia and complications in 1,416 patients. Anesthesiology. 2005 Nov;103(5):1035-45. doi: 10.1097/00000542-200511000-00018.

    PMID: 16249678BACKGROUND
  • Choquet O, Noble GB, Abbal B, Morau D, Bringuier S, Capdevila X. Subparaneural versus circumferential extraneural injection at the bifurcation level in ultrasound-guided popliteal sciatic nerve blocks: a prospective, randomized, double-blind study. Reg Anesth Pain Med. 2014 Jul-Aug;39(4):306-11. doi: 10.1097/AAP.0000000000000095.

    PMID: 24918330BACKGROUND
  • Dalkilic N, Tuncer S, Burat I. Dexmedetomidine augments the effect of lidocaine: power spectrum and nerve conduction velocity distribution study. BMC Anesthesiol. 2015 Mar 6;15:24. doi: 10.1186/s12871-015-0009-9. eCollection 2015.

    PMID: 25762864BACKGROUND
  • De Buck F, Devroe S, Missant C, Van de Velde M. Regional anesthesia outside the operating room: indications and techniques. Curr Opin Anaesthesiol. 2012 Aug;25(4):501-7. doi: 10.1097/ACO.0b013e3283556f58.

    PMID: 22673788BACKGROUND
  • Desmet M, Braems H, Reynvoet M, Plasschaert S, Van Cauwelaert J, Pottel H, Carlier S, Missant C, Van de Velde M. I.V. and perineural dexamethasone are equivalent in increasing the analgesic duration of a single-shot interscalene block with ropivacaine for shoulder surgery: a prospective, randomized, placebo-controlled study. Br J Anaesth. 2013 Sep;111(3):445-52. doi: 10.1093/bja/aet109. Epub 2013 Apr 15.

    PMID: 23587875BACKGROUND
  • Drachman D, Strichartz G. Potassium channel blockers potentiate impulse inhibition by local anesthetics. Anesthesiology. 1991 Dec;75(6):1051-61. doi: 10.1097/00000542-199112000-00018.

    PMID: 1741497BACKGROUND
  • Durham SD, Flournoy N, Rosenberger WF. A random walk rule for phase I clinical trials. Biometrics. 1997 Jun;53(2):745-60.

    PMID: 9192462BACKGROUND
  • Elmas C, Atanassoff PG. Combined inguinal paravascular (3-in-1) and sciatic nerve blocks for lower limb surgery. Reg Anesth. 1993 Mar-Apr;18(2):88-92.

    PMID: 8489988BACKGROUND
  • Grape S, Kirkham KR, Baeriswyl M, Albrecht E. The analgesic efficacy of sciatic nerve block in addition to femoral nerve block in patients undergoing total knee arthroplasty: a systematic review and meta-analysis. Anaesthesia. 2016 Oct;71(10):1198-209. doi: 10.1111/anae.13568. Epub 2016 Jul 29.

    PMID: 27469381BACKGROUND
  • Green SB. How Many Subjects Does It Take To Do A Regression Analysis. Multivariate Behav Res. 1991 Jul 1;26(3):499-510. doi: 10.1207/s15327906mbr2603_7.

    PMID: 26776715BACKGROUND
  • Gupta PK, Pace NL, Hopkins PM. Effect of body mass index on the ED50 volume of bupivacaine 0.5% for supraclavicular brachial plexus block. Br J Anaesth. 2010 Apr;104(4):490-5. doi: 10.1093/bja/aeq017. Epub 2010 Feb 18.

    PMID: 20167584BACKGROUND
  • He M, Ling DD, Cai GY, Zou TX, Yu B. Two different placement paths in popliteal fossa with a novel nerve block needle for postoperative analgesia after foot and ankle surgery. Minerva Anestesiol. 2018 May;84(5):582-589. doi: 10.23736/S0375-9393.17.12061-4. Epub 2017 Oct 12.

    PMID: 29027771BACKGROUND
  • Kang R, Jeong JS, Yoo JC, Lee JH, Choi SJ, Gwak MS, Hahm TS, Huh J, Ko JS. Effective Dose of Intravenous Dexmedetomidine to Prolong the Analgesic Duration of Interscalene Brachial Plexus Block: A Single-Center, Prospective, Double-Blind, Randomized Controlled Trial. Reg Anesth Pain Med. 2018 Jul;43(5):488-495. doi: 10.1097/AAP.0000000000000773.

    PMID: 29630034BACKGROUND
  • Keplinger M, Marhofer P, Marhofer D, Schroegendorfer K, Haslik W, Zeitlinger M, Mayer CV, Kettner SC. Effective local anaesthetic volumes for sciatic nerve blockade: a clinical evaluation of the ED99. Anaesthesia. 2015 May;70(5):585-90. doi: 10.1111/anae.13013. Epub 2015 Jan 20.

    PMID: 25644578BACKGROUND
  • Kettner SC, Willschke H, Marhofer P. Does regional anaesthesia really improve outcome? Br J Anaesth. 2011 Dec;107 Suppl 1:i90-5. doi: 10.1093/bja/aer340.

    PMID: 22156274BACKGROUND
  • Latzke D, Marhofer P, Zeitlinger M, Machata A, Neumann F, Lackner E, Kettner SC. Minimal local anaesthetic volumes for sciatic nerve block: evaluation of ED 99 in volunteers. Br J Anaesth. 2010 Feb;104(2):239-44. doi: 10.1093/bja/aep368. Epub 2009 Dec 23.

    PMID: 20034967BACKGROUND
  • Lirk P, Hollmann MW, Strichartz G. The Science of Local Anesthesia: Basic Research, Clinical Application, and Future Directions. Anesth Analg. 2018 Apr;126(4):1381-1392. doi: 10.1213/ANE.0000000000002665.

    PMID: 29189280BACKGROUND
  • Marhofer P, Pilz-Lubsczyk B, Lonnqvist PA, Fleischmann E. Ultrasound-guided peripheral regional anaesthesia: a feasibility study in obese versus normal-weight women. Int J Obes (Lond). 2014 Mar;38(3):451-5. doi: 10.1038/ijo.2013.119. Epub 2013 Jun 25.

    PMID: 23797187BACKGROUND
  • Nathan N, Benrhaiem M, Lotfi H, Debord J, Rigaud G, Lachatre G, Adenis JP, Feiss P. The role of hyaluronidase on lidocaine and bupivacaine pharmacokinetics after peribulbar blockade. Anesth Analg. 1996 May;82(5):1060-4. doi: 10.1097/00000539-199605000-00032.

    PMID: 8610868BACKGROUND
  • O'Donnell BD, Iohom G. An estimation of the minimum effective anesthetic volume of 2% lidocaine in ultrasound-guided axillary brachial plexus block. Anesthesiology. 2009 Jul;111(1):25-9. doi: 10.1097/ALN.0b013e3181a915c7.

    PMID: 19512869BACKGROUND
  • Palmer CG, Jagannathan S. Sciatic nerve block and enhanced recovery after total knee arthroplasty. Anaesthesia. 2016 Dec;71(12):1495. doi: 10.1111/anae.13728. No abstract available.

    PMID: 27870171BACKGROUND
  • Raymond SA, Steffensen SC, Gugino LD, Strichartz GR. The role of length of nerve exposed to local anesthetics in impulse blocking action. Anesth Analg. 1989 May;68(5):563-70.

    PMID: 2785778BACKGROUND

MeSH Terms

Conditions

AgnosiaPain, Postoperative

Interventions

LidocaineSufentanil

Condition Hierarchy (Ancestors)

Perceptual DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsPostoperative ComplicationsPathologic ProcessesPain

Intervention Hierarchy (Ancestors)

AcetanilidesAnilidesAmidesOrganic ChemicalsAniline CompoundsAminesFentanylPiperidinesHeterocyclic Compounds, 1-RingHeterocyclic Compounds

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Masking Details
The study is open-label (unblinded). Because the IPCIL group required an additional intrapleural infusion pump that was not present in the control group, blinding of both participants and investigators was not feasible.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: lidocaine will be injection by electronic analgesic pump, and the pulse infusion speed is 1ml / 30min, and 2ml / h for continuous infusion
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
the attending doctor

Study Record Dates

First Submitted

May 3, 2023

First Posted

June 13, 2023

Study Start

June 7, 2023

Primary Completion

December 22, 2023

Study Completion

December 30, 2023

Last Updated

September 24, 2026

Record last verified: 2023-07

Locations